T4 glottic carcinoma: Oncological results and survival rate

HealthMED

Volumn 6, Issue 1, 2012, Pages 181-187

  Jancic, Slavisa ^a   Zivic, Misko ^a   Radovanovic, Zoran ^a   Milicic, Biljana ^b   Djindjic, Natasa ^c   Djindjic, Boris ^c   Jancic, Snezana ^d  

^a CLINICAL CENTER NIS   (Serbia)

^b Department of statistics   (Serbia)

^c UNIVERSITY OF NI   (Serbia)

^d Faculty of Medicine in Kragujevac   (Serbia)

Author keywords

Postoperative radiotherapy; Prognostic factors; Radical radiotherapy; Survival; T4 glottic cancer

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; CONSERVATIVE TREATMENT; FEMALE; HUMAN; LARYNX SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEGAVOLTAGE RADIATION; POSTOPERATIVE RADIOTHERAPY; RADIATION DOSE FRACTIONATION; RADICAL RADIOTHERAPY; RETROSPECTIVE STUDY; SEX; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

EID: 84856999350     PISSN: 18402291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Devlin JG, Langer CJ. Combined modality treatment of laryngeal squamous cell carcinoma. Expert Rev Anticancer Ther 2007; 7 (3): 331-350.
2. Hinni ML, Salssa JR, Grant DG, et al. Transoral laser microsurgery for advanced laryngeal cancer. Arch Otorynol Head Neck Surg 2007; 133 (12): 1198-1204.
3. Ampill FL, Nathan CA, Caldito G, et al. Total laringectomy and postoperative radiotherapy for T4 laryngeal cancer, a 14 year review. Am J Otolaryngol 2004; 25(2):88-93.
4. Spiric P, Spiric S, Stankovic M. Modified technique of total laryngectomy. Acta Medica Medianae 2010; 49(4):39-42.
5. Jones T, Parsons MD, Willam M, et al. T4 laringeal carcinoma: Radiotherapy alone with surgery reserved for salvage, Int. J Radiation Oncol Biol Phys 1998; 40:549-552.
6. National Comprehesive Cancer Network: Practice Guidelines in Oncology: Head and Neck Cancers. Version 1, 2001.
7. Vokes EE, Kies MS, Haraf DJ, et al. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol 2000; 8:1652-1661.
8. Iseli TA, Brown CL, Sizeland AM, Berkowitz RG. Palliative surgery for neoplastic unilateral vocal cord paralysis. ANZ J Surg 2001;71(11):672-674.
9. Spector JG, Sessions DG, Lenox J, et al. Menamegent of stage IV glottic carcinoma. therapeutic outcomes. Laringoscope 2004; 114:1438-1446.
10. Chung CK, Chung JS, Brace KC, Modlin B. Radiotherapy for cancer of the Larynx: review of a communit hospital experience. Md Med J 1994; 43: 971-975.
11. International Union against Cancer (UICC): TNM Classification of malignant tumour. 5th ed, 2nd revision. Heidelberg, Germany: Springer, 1992.
12. Hinerman RW, Mendenhall WM, Morrs CG, Amdur RJ, Werning JW, Villaret DB. T3 and T4 true vocal cord squamous carcinomas treated with external beam irradiation: a single institutions 35-year experience. Am J Clin Oncol 2007; 30(2): 181-185.
13. Tian WD, Zeng ZY, Chen FJ, Wu GH, Guo ZM, Zhang O. Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma. Ai Zheng 2006; 25 (1): 80-84.
14. Yamazaki H, Nishiyama K, Tanaka E et al. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J of Radiation Oncol Biol Physics 2006; 64:77-82.
15. Schwartz DL, Barker J Jr, Chansky K, Yueh B, Raminfar L, Cha C. Postradiotherapy surveillance practice for head and neck squamous cell carcinoma-- too much for too little? Head Neck 2003; 25(12):990-999.
16. Bergqvist M, Brodin O, Linder A, Hesselius P, Blomquist E. Radiation treatment of T1-T4 squamous cell carcinoma of the larinx: a retrospective analysis and long-term follow-up of 135 patients. Anticancer Res 2002; 22(28):1239-1242.
17. Nguyen-Tan PF, Le Quivey JM, Singer M, Terris DJ, Goffinet DR, Fu KK. Treatment results and prognostic factors of advanced T3-T4 laryngeal carcinoma: the University Hospital (SUH)experience. Int J Radiat Oncol Biol Phys 2001; 1:50 (5): 1172-1180.
18. Vlachtsis K, Nikolaou A, Markou K, Fountzilas G, Daniilidis I. Clinical and molecular prognostic factors in operable laryngeal cancer. Eur Arch Otorhinolaryngol 2005; 262(11):890-898.
19. Novakovic B, Jovicic J, Milic N, Jusupovic F, Grujicic M, Djuric D. Nutrition care process in cancer. Healthmed 2010; 4(2): 427-433
20. Raitiola H, Pukander J, Laippala P. Glottic and supraglottic laryngeal carcinoma: differences in epidemiology,clinical characteristics and prognosis. Acta Otolaryngol 1999; 119(7):847-851.
21. Vallicioni JM, Giovani A, Triglia JM, Zanaret M. Laringeal cancer in young adult. Press Med 1999; 78:908-910.
22. Bien S, Kaninski R, Zylka S, et al: The evaluation of epidemiology and clinical chaeacteristics of laryngeal carcinoma in Poland. Otolaryngeol Pol 2005; 59:169-181.
23. Sas-Korczynska H, Korzeniowski S. Cancer of the larinx in females. Cancer Radiother 2003; 7: 380-385.
24. Ibrulj S, Haveric A, Haveric S, Rahmanovic A, Alendar F. Basal Cell Carcinoma: Cultivation Potential and Results of Chromosome Aberrations Analysis. Healthmed 2010; 4(3): 605-609
25. Van Putten WLJ, Van der Sangen MJC, Hoekstra CJM et al. Dose, fractionation and overall treatment time in radiation therapy - the effects on local control for cancer of the larynx. Radiother Oncol 1994; 30:97-108.
26. Le QT, Fu KK, Kroll S, et al. Influence of fraction size, total dose and overall time on local control of T1-T2 glottic carcinoma. Int. J Radiation Oncol Biol Phys 1997; 39: 115-126.
27. Fu KK, Wodhouse RJ, Quivey JM et al. The significance of laryngeal edema following radiotherapy of carcinoma of the vocal cord. Cancer 1982; 49:655-658.
28. Leon X, Quer M, Orus C, Lopez-Pousa A, Pericay C, Vega M. How much does it cost to preserve a larynx? An economic study. Eur Arch Otorhinolaryngol 2000; 257(2):72-76.
29. Yamazaki H, Nishiyama K, Tanaka E et al: Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J of Radiation Oncol, Biol, Physics,2006, 64:77-82.
30. Yu WB, Zeng ZY, Chen FJ, Peng HW: Treatment and prognosis of stage T3 glottic laryngeal cancer - a report of 65 cases. Ai Zheng, 2006, 25(1): 85-87.